A Duchenne therapy lawsuit, FDA Commissioner Marty Makary’s White House troubles, and other news from The Readout
Adobe
By Meghana Keshavan
May 8, 2026
Biotech Correspondent
Meghana Keshavan
Diamantas takes the reins, Regenxbio stakes claim in Duchenne gene therapy, and more biotech news from The Readout
AstraZeneca, Ionis report major trial failure, White House pushes for American drug manufacturing, and more biotech news from The…
The FDA is “willing to review” an updated submission for Capricor’s Duchenne cell therapy, its CEO said. Elsewhere, a heart drug…
Alzheimer's drug rollout letdown, a China-based heart drug startup, and more biotech news from The Readout
Secret drug pricing deals, a virtual AI cancer clinic, and other biotech news from The Readout
What Soon-Shiong has delivered, Encanta's RSV antiviral, and other biotech news from The Readout
